EichorEICHOR
Location: Auckland Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Auckland

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease
NA · Auckland City Hospital · Efemoral Medical, Inc. · NCT04584632A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · North Shore Hospital · Pfizer · NCT05020236A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Phase 3 · North Shore Hospital-Department of Haematology ( Site 1401) · Merck Sharp & Dohme LLC · NCT06351631Precision Medicine for Every Child With Cancer
Phase N/A · Starship Children's Hospital · Australian & New Zealand Children's Haematology/Oncology Gro · NCT05504772SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry
Phase N/A · Auckland City Hospital · Galaxy Therapeutics INC · NCT05880680This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Auckland City Hospital · Pfizer · NCT07028853A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma
Phase 2 · Auckland City Hospital · Malaghan Institute of Medical Research · NCT06486051A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase 2/Phase 3 · Starship Children's Hospital · University of Birmingham · NCT05991388Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Starship Children's Hospital · Princess Maxima Center for Pediatric Oncology · NCT05327894A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · North Shore Hospital-Department of Haematology ( Site 3200) · Merck Sharp & Dohme LLC · NCT06136559A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · National Cancer Institute (NCI) · NCT05099003A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · North Shore Hospital · Bristol-Myers Squibb · NCT06929273Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · National Cancer Institute (NCI) · NCT06172296Antimicrobial Stewardship Effects of Interpretive Comments for Faecal PCR Tests
NA · Awanui Labs Auckland · Medical Research Institute of New Zealand · NCT07701135A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With
Phase 1/Phase 2 · Auckland Cancer Trial Centre · Hoffmann-La Roche · NCT05987449PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Pacific Clinical Research Network - Auckland · Boehringer Ingelheim · NCT07355296Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
Phase 1 · Pacific Clinical Research Network-West Auckland · TRex Bio, Inc. · NCT06934252A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Harbour Cancer and Wellness · Hoffmann-La Roche · NCT06793215Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · PedAL BCU, LLC · NCT05183035A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05691478A Platform Trial for Gram Negative Bloodstream Infections
NA · Middlemore Hospital · Sunnybrook Health Sciences Centre · NCT06537609Quality of Pediatric Resuscitation in a Multicenter Collaborative
Phase N/A · Starship Children's Hospital · Children's Hospital of Philadelphia · NCT02708134Combination Therapy for the Treatment of Diffuse Midline Gliomas
Phase 2 · Starship Children's Hospital · University of California, San Francisco · NCT05009992Nicotine Patch Plus Nicotine Mouth Spray Versus Nicotine Reduction for Vaping Cessation
Phase 3 · School of Population Health, Faculty of Medical and Health S · University of Auckland, New Zealand · NCT06832098SELUTION4BTK Trial
NA · Auckland City Hospital · M.A. Med Alliance S.A. · NCT05055297A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Children's Oncology Group · NCT04322318Depth of Anesthesia on Postoperative Delirium and Cognitive After Surgery
NA · North Shore Hospital · Auckland City Hospital · NCT06268080ROADMAP Clinical Trial
Phase 4 · University of Newcastle, Australia · NCT06771050A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Harbour Cancer & Wellness ( Site 0301) · Merck Sharp & Dohme LLC · NCT06077760A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0369 · Celgene · NCT05519085
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.